Feng Tang

577 total citations
18 papers, 419 citations indexed

About

Feng Tang is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Feng Tang has authored 18 papers receiving a total of 419 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Oncology and 4 papers in Cancer Research. Recurrent topics in Feng Tang's work include MicroRNA in disease regulation (3 papers), HER2/EGFR in Cancer Research (3 papers) and Neuroendocrine Tumor Research Advances (2 papers). Feng Tang is often cited by papers focused on MicroRNA in disease regulation (3 papers), HER2/EGFR in Cancer Research (3 papers) and Neuroendocrine Tumor Research Advances (2 papers). Feng Tang collaborates with scholars based in China and United States. Feng Tang's co-authors include Kelly K. Hunt, Bing Wei, Yan Xing, Zhen Tian, Wei Wei, Yun Wu, Susan C. Abraham, Tian Ding, Khazi M. Nayeemuddin and Lan Mi and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer.

In The Last Decade

Feng Tang

17 papers receiving 413 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Feng Tang China	11	163	131	120	118	111	18	419
Shinichiro Tahara Japan	12	208 1.3×	45 0.3×	87 0.7×	116 1.0×	24 0.2×	35	449
Rebecca Millican‐Slater United Kingdom	14	220 1.3×	108 0.8×	204 1.7×	168 1.4×	12 0.1×	29	548
Martin Udart Germany	10	248 1.5×	24 0.2×	47 0.4×	214 1.8×	50 0.5×	15	428
Catherine F. Cowell United States	7	204 1.3×	121 0.9×	237 2.0×	193 1.6×	13 0.1×	8	480
Sathya Muralidhar United Kingdom	7	111 0.7×	47 0.4×	39 0.3×	125 1.1×	28 0.3×	8	292
Ashkan Shahbandi United States	7	231 1.4×	22 0.2×	124 1.0×	200 1.7×	24 0.2×	11	507
Eldo T. Verghese United Kingdom	15	322 2.0×	39 0.3×	258 2.1×	198 1.7×	26 0.2×	29	610
Maddalena T. Tilli United States	12	300 1.8×	23 0.2×	112 0.9×	280 2.4×	16 0.1×	17	596
Sk. Kayum Alam United States	12	312 1.9×	21 0.2×	125 1.0×	164 1.4×	29 0.3×	18	461
Inbar Azoulay‐Alfaguter United States	11	200 1.2×	33 0.3×	35 0.3×	284 2.4×	69 0.6×	21	617

Countries citing papers authored by Feng Tang

Since Specialization

Citations

This map shows the geographic impact of Feng Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feng Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feng Tang more than expected).

Fields of papers citing papers by Feng Tang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feng Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feng Tang. The network helps show where Feng Tang may publish in the future.

Co-authorship network of co-authors of Feng Tang

This figure shows the co-authorship network connecting the top 25 collaborators of Feng Tang. A scholar is included among the top collaborators of Feng Tang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feng Tang. Feng Tang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Li, Jian, Yu Duan, Guohui Huang, et al.. (2025). Global research trends in CAR-T cell therapy for glioblastoma: a bibliometric and visualized analysis. Discover Oncology. 16(1). 1770–1770.

Duan, Yu, Yao Deng, Feng Tang, & Jian Li. (2024). Lifibrate attenuates blood-brain barrier damage following ischemic stroke via the MLCK/p-MLC/ZO-1 axis. Aging. 16(7). 6135–6146. 1 indexed citations

Xie, Shichao, Tingting Zhu, Wenli Zhao, et al.. (2024). Valine biased glycogen consumption to promote energy metabolism of Portunus trituberculatus and increased protein and essential amino acid deposition in muscle. Aquaculture Reports. 38. 102322–102322. 1 indexed citations

Zhang, Zijing, Hongying Wang, Yiting Jin, et al.. (2023). KRT15 in Early Breast Cancer Screening and Correlation with HER2 Positivity, Pathological Grade and N Stage. Biomarkers in Medicine. 17(12). 553–562. 3 indexed citations

Zhang, Zijing, Hongying Wang, Yiting Jin, et al.. (2022). Potential of blood exosomal ENAH, SEPT9, EGF, MMP‑9 and CXCL8 for the early screening of breast cancer. Oncology Letters. 24(6). 460–460. 2 indexed citations

Yang, Chen, Qiong Li, Xinan Chen, et al.. (2020). Circular RNA circRGNEF promotes bladder cancer progression via miR-548/KIF2C axis regulation. Aging. 12(8). 6865–6879. 36 indexed citations

Zhang, Zijing, Yiting Jin, Wei Zhang, et al.. (2019). Values of 5mC, 5hmC, and TET2 for identifying the presence and progression of breast precancerous lesion. Journal of Clinical Laboratory Analysis. 34(5). e23162–e23162. 11 indexed citations

Ren, Kehan, Jigang Wang, Hong Ren, et al.. (2018). Erythropoietin-producing hepatocellular A6 overexpression is a novel biomarker of poor prognosis in patients with breast cancer. Oncology Letters. 15(4). 5257–5263. 10 indexed citations

Tang, Feng, et al.. (2017). Rapid diagnosis and intraoperative margin assessment of human lung cancer with fluorescence lifetime imaging microscopy. SHILAP Revista de lepidopterología. 8. 7–13. 53 indexed citations

10.

Bao, Yun, et al.. (2017). Down-regulation of C35 decreased the cell viability and migration of breast ductal carcinoma cells. PLoS ONE. 12(8). e0183941–e0183941. 1 indexed citations

11.

Tang, Feng, Xinyi Wang, Jiong Ma, et al.. (2016). Autofluorescence Imaging and Spectroscopy of Human Lung Cancer. Applied Sciences. 7(1). 32–32. 22 indexed citations

12.

Xue, Huiping, Yan Lü, Bing Lin, et al.. (2014). The effect of CYP1A1 and CYP1A2 polymorphisms on gastric cancer risk among different ethnicities: a systematic review and meta-analysis. Tumor Biology. 35(5). 4741–4756. 17 indexed citations

13.

Fang, Yantian, Jianbin Xiang, Zongyou Chen, et al.. (2012). miRNA expression profile of colon cancer stem cells compared to non-stem cells using the SW1116 cell line. Oncology Reports. 28(6). 2115–2124. 26 indexed citations

14.

Tian, Zhen, Bing Wei, Feng Tang, et al.. (2011). Prognostic significance of tumor grading and staging in mammary carcinomas with neuroendocrine differentiation. Human Pathology. 42(8). 1169–1177. 39 indexed citations

15.

Wei, Bing, Tian Ding, Yan Xing, et al.. (2010). Invasive neuroendocrine carcinoma of the breast. Cancer. 116(19). 4463–4473. 124 indexed citations

16.

Tang, Feng, et al.. (2008). Interaction between CD147 and P-Glycoprotein and Their Regulation by Ubiquitination in Breast Cancer Cells. Chemotherapy. 54(4). 291–301. 31 indexed citations

17.

Cao, Xi-Xi, et al.. (2008). The role of P-glycoprotein/cellular prion protein interaction in multidrug-resistant breast cancer cells treated with paclitaxel. Cellular and Molecular Life Sciences. 66(3). 504–515. 41 indexed citations

18.

Tang, Feng, et al.. (2006). [Expression and significance of hTERT mRNA in breast carcinoma and its relation to p53].. PubMed. 28(3). 192–5. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact